Serveur d'exploration sur le lymphœdème

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Sulfuretin has therapeutic activity against acquired lymphedema by reducing adipogenesis.

Identifieur interne : 000155 ( Main/Exploration ); précédent : 000154; suivant : 000156

Sulfuretin has therapeutic activity against acquired lymphedema by reducing adipogenesis.

Auteurs : Kangsan Roh [Corée du Sud] ; Suji Kim [Corée du Sud] ; Hee Kang [Corée du Sud] ; Jin-Mo Ku [Corée du Sud] ; Kye Won Park [Corée du Sud] ; Sukchan Lee [Corée du Sud]

Source :

RBID : pubmed:28483479

Abstract

Acquired lymphedema is a pathological condition associated with lymphatic dysfunction caused by surgical treatments for cancer. Although global estimates of the prevalence of acquired lymphedema have been rising, there are currently no effective therapeutics available. Since adipose tissue accumulation is a clinical hallmark of lymphedema, we hypothesized that regulation of adipogenesis in lymphedematous tissue could be used as a therapeutic intervention against lymphedema. Toward this, we investigated the possibility of anti-adipogenic 30% ethanol Rhus verniciflua Stokes (RVS) extract as a potential lymphedema treatment. Oral administration of RVS extract ameliorated volumetric symptoms of lymphedema in a mouse model. RVS administration also reduced adipose tissue accumulation in lymphedematous tissue and downregulated expression of adipocyte markers, including Pparγ and Fabp4. Sulfuretin was identified as a major bioactive compound in the 30% ethanol RVS extract in liquid chromatography-mass spectrometry analysis. Similar to the activities of RVS, sulfuretin inhibited adipocyte differentiation in 3T3-L1 preadipocytes. Moreover, treatment with sulfuretin on lymphedema-induced mice reduced lymphedema volume, decreased the expression of adipogenic markers, but induced the expression of markers associated with lymphangiogenesis. Taken together, our data raise the possibility that sulfuretin might be used in therapeutic interventions against acquired lymphedema.

DOI: 10.1016/j.phrs.2017.05.003
PubMed: 28483479


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Sulfuretin has therapeutic activity against acquired lymphedema by reducing adipogenesis.</title>
<author>
<name sortKey="Roh, Kangsan" sort="Roh, Kangsan" uniqKey="Roh K" first="Kangsan" last="Roh">Kangsan Roh</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Genetic Engineering, Sungkyunkwan University, Suwon, 440-746, Republic of Korea.</nlm:affiliation>
<country xml:lang="fr">Corée du Sud</country>
<wicri:regionArea>Department of Genetic Engineering, Sungkyunkwan University, Suwon, 440-746</wicri:regionArea>
<wicri:noRegion>440-746</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Kim, Suji" sort="Kim, Suji" uniqKey="Kim S" first="Suji" last="Kim">Suji Kim</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Food Science & Biotechnology, Sungkyunkwan University, Suwon, 440-746, Republic of Korea.</nlm:affiliation>
<country xml:lang="fr">Corée du Sud</country>
<wicri:regionArea>Department of Food Science & Biotechnology, Sungkyunkwan University, Suwon, 440-746</wicri:regionArea>
<wicri:noRegion>440-746</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Kang, Hee" sort="Kang, Hee" uniqKey="Kang H" first="Hee" last="Kang">Hee Kang</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Oriental Medical Science, Graduate School of East-West Medicine, Kyunghee University, Secheondong, Yongin 446-701, Republic of Korea.</nlm:affiliation>
<country xml:lang="fr">Corée du Sud</country>
<wicri:regionArea>Department of Oriental Medical Science, Graduate School of East-West Medicine, Kyunghee University, Secheondong, Yongin 446-701</wicri:regionArea>
<wicri:noRegion>Yongin 446-701</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Ku, Jin Mo" sort="Ku, Jin Mo" uniqKey="Ku J" first="Jin-Mo" last="Ku">Jin-Mo Ku</name>
<affiliation wicri:level="1">
<nlm:affiliation>Natural Products Research Department, Gyeonggi Institute of Science & Technology Promotion, Suwon, 443-270, Republic of Korea.</nlm:affiliation>
<country xml:lang="fr">Corée du Sud</country>
<wicri:regionArea>Natural Products Research Department, Gyeonggi Institute of Science & Technology Promotion, Suwon, 443-270</wicri:regionArea>
<wicri:noRegion>443-270</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Park, Kye Won" sort="Park, Kye Won" uniqKey="Park K" first="Kye Won" last="Park">Kye Won Park</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Food Science & Biotechnology, Sungkyunkwan University, Suwon, 440-746, Republic of Korea.</nlm:affiliation>
<country xml:lang="fr">Corée du Sud</country>
<wicri:regionArea>Department of Food Science & Biotechnology, Sungkyunkwan University, Suwon, 440-746</wicri:regionArea>
<wicri:noRegion>440-746</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Lee, Sukchan" sort="Lee, Sukchan" uniqKey="Lee S" first="Sukchan" last="Lee">Sukchan Lee</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Genetic Engineering, Sungkyunkwan University, Suwon, 440-746, Republic of Korea. Electronic address: cell4u@skku.edu.</nlm:affiliation>
<country xml:lang="fr">Corée du Sud</country>
<wicri:regionArea>Department of Genetic Engineering, Sungkyunkwan University, Suwon, 440-746</wicri:regionArea>
<wicri:noRegion>440-746</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2017">2017</date>
<idno type="RBID">pubmed:28483479</idno>
<idno type="pmid">28483479</idno>
<idno type="doi">10.1016/j.phrs.2017.05.003</idno>
<idno type="wicri:Area/PubMed/Corpus">000219</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000219</idno>
<idno type="wicri:Area/PubMed/Curation">000219</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000219</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000219</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000219</idno>
<idno type="wicri:Area/Ncbi/Merge">009048</idno>
<idno type="wicri:Area/Ncbi/Curation">009048</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">009048</idno>
<idno type="wicri:Area/Main/Merge">000155</idno>
<idno type="wicri:Area/Main/Curation">000155</idno>
<idno type="wicri:Area/Main/Exploration">000155</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Sulfuretin has therapeutic activity against acquired lymphedema by reducing adipogenesis.</title>
<author>
<name sortKey="Roh, Kangsan" sort="Roh, Kangsan" uniqKey="Roh K" first="Kangsan" last="Roh">Kangsan Roh</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Genetic Engineering, Sungkyunkwan University, Suwon, 440-746, Republic of Korea.</nlm:affiliation>
<country xml:lang="fr">Corée du Sud</country>
<wicri:regionArea>Department of Genetic Engineering, Sungkyunkwan University, Suwon, 440-746</wicri:regionArea>
<wicri:noRegion>440-746</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Kim, Suji" sort="Kim, Suji" uniqKey="Kim S" first="Suji" last="Kim">Suji Kim</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Food Science & Biotechnology, Sungkyunkwan University, Suwon, 440-746, Republic of Korea.</nlm:affiliation>
<country xml:lang="fr">Corée du Sud</country>
<wicri:regionArea>Department of Food Science & Biotechnology, Sungkyunkwan University, Suwon, 440-746</wicri:regionArea>
<wicri:noRegion>440-746</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Kang, Hee" sort="Kang, Hee" uniqKey="Kang H" first="Hee" last="Kang">Hee Kang</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Oriental Medical Science, Graduate School of East-West Medicine, Kyunghee University, Secheondong, Yongin 446-701, Republic of Korea.</nlm:affiliation>
<country xml:lang="fr">Corée du Sud</country>
<wicri:regionArea>Department of Oriental Medical Science, Graduate School of East-West Medicine, Kyunghee University, Secheondong, Yongin 446-701</wicri:regionArea>
<wicri:noRegion>Yongin 446-701</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Ku, Jin Mo" sort="Ku, Jin Mo" uniqKey="Ku J" first="Jin-Mo" last="Ku">Jin-Mo Ku</name>
<affiliation wicri:level="1">
<nlm:affiliation>Natural Products Research Department, Gyeonggi Institute of Science & Technology Promotion, Suwon, 443-270, Republic of Korea.</nlm:affiliation>
<country xml:lang="fr">Corée du Sud</country>
<wicri:regionArea>Natural Products Research Department, Gyeonggi Institute of Science & Technology Promotion, Suwon, 443-270</wicri:regionArea>
<wicri:noRegion>443-270</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Park, Kye Won" sort="Park, Kye Won" uniqKey="Park K" first="Kye Won" last="Park">Kye Won Park</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Food Science & Biotechnology, Sungkyunkwan University, Suwon, 440-746, Republic of Korea.</nlm:affiliation>
<country xml:lang="fr">Corée du Sud</country>
<wicri:regionArea>Department of Food Science & Biotechnology, Sungkyunkwan University, Suwon, 440-746</wicri:regionArea>
<wicri:noRegion>440-746</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Lee, Sukchan" sort="Lee, Sukchan" uniqKey="Lee S" first="Sukchan" last="Lee">Sukchan Lee</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Genetic Engineering, Sungkyunkwan University, Suwon, 440-746, Republic of Korea. Electronic address: cell4u@skku.edu.</nlm:affiliation>
<country xml:lang="fr">Corée du Sud</country>
<wicri:regionArea>Department of Genetic Engineering, Sungkyunkwan University, Suwon, 440-746</wicri:regionArea>
<wicri:noRegion>440-746</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series>
<title level="j">Pharmacological research</title>
<idno type="eISSN">1096-1186</idno>
<imprint>
<date when="2017" type="published">2017</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass></textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Acquired lymphedema is a pathological condition associated with lymphatic dysfunction caused by surgical treatments for cancer. Although global estimates of the prevalence of acquired lymphedema have been rising, there are currently no effective therapeutics available. Since adipose tissue accumulation is a clinical hallmark of lymphedema, we hypothesized that regulation of adipogenesis in lymphedematous tissue could be used as a therapeutic intervention against lymphedema. Toward this, we investigated the possibility of anti-adipogenic 30% ethanol Rhus verniciflua Stokes (RVS) extract as a potential lymphedema treatment. Oral administration of RVS extract ameliorated volumetric symptoms of lymphedema in a mouse model. RVS administration also reduced adipose tissue accumulation in lymphedematous tissue and downregulated expression of adipocyte markers, including Pparγ and Fabp4. Sulfuretin was identified as a major bioactive compound in the 30% ethanol RVS extract in liquid chromatography-mass spectrometry analysis. Similar to the activities of RVS, sulfuretin inhibited adipocyte differentiation in 3T3-L1 preadipocytes. Moreover, treatment with sulfuretin on lymphedema-induced mice reduced lymphedema volume, decreased the expression of adipogenic markers, but induced the expression of markers associated with lymphangiogenesis. Taken together, our data raise the possibility that sulfuretin might be used in therapeutic interventions against acquired lymphedema.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>Corée du Sud</li>
</country>
</list>
<tree>
<country name="Corée du Sud">
<noRegion>
<name sortKey="Roh, Kangsan" sort="Roh, Kangsan" uniqKey="Roh K" first="Kangsan" last="Roh">Kangsan Roh</name>
</noRegion>
<name sortKey="Kang, Hee" sort="Kang, Hee" uniqKey="Kang H" first="Hee" last="Kang">Hee Kang</name>
<name sortKey="Kim, Suji" sort="Kim, Suji" uniqKey="Kim S" first="Suji" last="Kim">Suji Kim</name>
<name sortKey="Ku, Jin Mo" sort="Ku, Jin Mo" uniqKey="Ku J" first="Jin-Mo" last="Ku">Jin-Mo Ku</name>
<name sortKey="Lee, Sukchan" sort="Lee, Sukchan" uniqKey="Lee S" first="Sukchan" last="Lee">Sukchan Lee</name>
<name sortKey="Park, Kye Won" sort="Park, Kye Won" uniqKey="Park K" first="Kye Won" last="Park">Kye Won Park</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000155 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000155 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    LymphedemaV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:28483479
   |texte=   Sulfuretin has therapeutic activity against acquired lymphedema by reducing adipogenesis.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:28483479" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a LymphedemaV1 

Wicri

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024